EndoQuest Robotics Stock

www.endoquestrobotics.comHealthcare / Medical DevicesFounded: 2016Funding to Date: $156.48MM

EndoQuest Robotics, founded in 2016, is a medical equipment manufacturing startup striving to create a flexible endoluminal robotic surgical system. The system is designed to help surgeons and endoscopists to execute minimally invasive surgery through the body’s natural orifices. Their Flexible Robotic Surgery (FRS) System aims to reduce external incisions in healthy tissue that surgeons would typically need to penetrate. EndoQuest Robotics is headquartered in Houston, Texas.

Register To Buy and Sell Shares

For more details on financing and valuation for EndoQuest Robotics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access EndoQuest Robotics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like EndoQuest Robotics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

EndoQuest Robotics investors also invested in these private companies

Mithril Capital Management
Puma Venture Capital
McNair Interests
CE-Ventures

Team

Management Team

Kurt Azarbarzin
Chief Executive Officer
Christine Antalik
Chief Financial Officer
Todd Wilson MD
Chief Medical Officer
Perry Genova
Senior Vice President, Research & Development
Chris Klecher
Senior Vice President, Marketing & Clinical Development

Board Members

Neeraj Agrawal
Crescent Group
Cary McNair
McNair Interests
Eduardo Fonseca
Crescent Group

Frequently Asked Questions About EndoQuest Robotics’ Stock

plusminus
Can you buy EndoQuest Robotics’ stock?
EndoQuest Robotics is not publicly traded on NYSE or NASDAQ in the U.S. To buy EndoQuest Robotics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell EndoQuest Robotics’ stock?
Yes, you can sell stock of a private company like EndoQuest Robotics. Forge can help you sell your EndoQuest Robotics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is EndoQuest Robotics’ stock price?
EndoQuest Robotics is a privately held company and therefore does not have a public stock price. However, you may access EndoQuest Robotics’ private market stock price with Forge Data.
plusminus
What is EndoQuest Robotics’ stock ticker symbol?
EndoQuest Robotics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

EndoQuest™ Robotics Closes $42 Million in Financing to Advance Endoluminal Robotics Technology
EndoQuest Robotics, Inc., (the "Company") a privately-held medical device company and pioneering leader in the development of innovative endoluminal robotic technologies, announced today the successful closure of a $42 million C-1 preferred financing round. This strategic funding will fuel the advancement of its groundbreaking flexible endoluminal robot aimed at transforming minimally invasive procedures.
Updated on: Mar 2, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.